01 6Lundbeck Canada Inc.
01 21339452
02 22373757
03 22612827
01 6Escitalopram
01 6Orodispersible Tablet
01 22014-09-09
02 22020-07-07
03 22026-06-22
Patent Expiration Date : 2014-09-09
Date Granted : 1997-09-09
Brand Name : CIPRALEX MELTZ
Patent Number : 1339452
Filing Date : 1989-06-13
Strength per Unit : 10 mg
Dosage Form : Orodispersible Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-09
Date Granted : 1997-09-09
Patent Expiration Date : 2020-07-07
Date Granted : 2010-01-05
Brand Name : CIPRALEX MELTZ
Patent Number : 2373757
Filing Date : 2000-07-07
Strength per Unit : 10 mg
Dosage Form : Orodispersible Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-07-07
Date Granted : 2010-01-05
Patent Expiration Date : 2026-06-22
Date Granted : 2010-11-30
Brand Name : CIPRALEX MELTZ
Patent Number : 2612827
Filing Date : 2006-06-22
Strength per Unit : 10 mg
Dosage Form : Orodispersible Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-06-22
Date Granted : 2010-11-30
Patent Expiration Date : 2014-09-09
Date Granted : 1997-09-09
Brand Name : CIPRALEX MELTZ
Patent Number : 1339452
Filing Date : 1989-06-13
Strength per Unit : 20 mg
Dosage Form : Orodispersible Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-09
Date Granted : 1997-09-09
Patent Expiration Date : 2020-07-07
Date Granted : 2010-01-05
Brand Name : CIPRALEX MELTZ
Patent Number : 2373757
Filing Date : 2000-07-07
Strength per Unit : 20 mg
Dosage Form : Orodispersible Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-07-07
Date Granted : 2010-01-05
Patent Expiration Date : 2026-06-22
Date Granted : 2010-11-30
Brand Name : CIPRALEX MELTZ
Patent Number : 2612827
Filing Date : 2006-06-22
Strength per Unit : 20 mg
Dosage Form : Orodispersible Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-06-22
Date Granted : 2010-11-30
